Athira Sethu
Kochi, 16 April 2025
Cognizant Technology Solutions has requested a US court to dismiss all the legal allegations levelled by Infosys, reports said. This is part of an ongoing court battle between the two large IT firms that has continued for eight months.
Infosys had previously accused Cognizant of attempting to stifle competition in the healthcare software market. According to Infosys, Cognizant employed unfair practices to prevent Infosys’s healthcare product, Helix, from competing with Cognizant’s own product, TriZetto.
In its most recent reply, Cognizant informed the court that Infosys failed to provide sufficient facts or evidence to substantiate its arguments. Cognizant stated that Infosys’s submissions were ambiguous and failed to define who the actual competitors were and what precise services were under discussion.
Cognizant stated that Infosys’s arguments regarding monopoly power and unfair competition were weak. They stated that Infosys is only speculating, without demonstrating actual evidence. Cognizant contended that merely holding a 65% market share is not sufficient to establish it has a monopoly, as the legal threshold tends to be 70% or higher.
Infosys had also indicated that Cognizant was overcharging and cutting back on service in order to maintain control of the market. Cognizant replied that the allegation made no sense and was not in accordance with facts. They also indicated that Infosys had already been successful in penetrating the market with multi-million-dollar contracts.
Infosys also blamed Cognizant for poaching some of its best employees, including Ravi Kumar S, who is currently the CEO at Cognizant. Cognizant responded that poaching employees from other firms is not prohibited by law and is standard in business.
Cognizant also stated that Infosys was improperly applying an uncommon legal principle that could be used only in rare instances when a company harms itself for the sole purpose of damaging a competitor. Infosys has no evidence this occurred, Cognizant said.
The two companies have not publicly commented so far. The court case is still pending.
